View Post

Modified drug combination may reduce risk of recurrence for some breast cancer patients

In In The News by Barbara Jacoby

By: Virginia Commonwealth University From: medicalxpress.com Oncologists at VCU Massey Cancer Center were invited to co-author an editorial published in the Journal of Clinical Oncology providing expert commentary on findings from a large study conducted by German investigators that a modified drug combination may lead to a decreased chance of disease recurrence for women with high risk, HER-2 negative breast …

View Post

PET scans show biomarkers could spare some breast cancer patients from chemotherapy

In In The News by Barbara Jacoby

Source: Johns Hopkins Medicine From: sciencedaily.com In an effort to further individualize therapy and avoid over-treating patients, researchers at the Johns Hopkins Kimmel Cancer Center report a new study using PET scans has identified a biomarker that may accurately predict which patients with one type of HER2-positive breast cancer might best benefit from standalone HER2-targeted agents, without the need for …